These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16917426)

  • 1. Surgical critical care: fungal infections in surgical patients.
    Lipsett PA
    Crit Care Med; 2006 Sep; 34(9 Suppl):S215-24. PubMed ID: 16917426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of candidiasis in the intensive care unit.
    Schelenz S
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i31-4. PubMed ID: 18063602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.
    Bassetti M; Righi E; Tumbarello M; Di Biagio A; Rosso R; Viscoli C
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):875-85. PubMed ID: 17140362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic fungal infections in the critically ill.
    Shelton BK
    Crit Care Nurs Clin North Am; 2000 Sep; 12(3):323-40. PubMed ID: 11855237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of antifungal prophylaxis among patients undergoing surgery.
    Calandra T; Marchetti O
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S185-92. PubMed ID: 15546116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing fungal infections in the intensive care unit.
    De Pauw BE
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK
    Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections in the ICU.
    Zilberberg MD; Shorr AF
    Infect Dis Clin North Am; 2009 Sep; 23(3):625-42. PubMed ID: 19665087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
    Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
    Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Candida infections in the neonate.
    Brian Smith P; Steinbach WJ; Benjamin DK
    Drug Resist Updat; 2005 Jun; 8(3):147-62. PubMed ID: 16002326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida infections in the intensive care unit.
    Sobel JD
    Crit Care Clin; 1988 Apr; 4(2):325-44. PubMed ID: 3048590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
    Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
    Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.